A B S T R A C T Kinetics of 5a-androstane-3a, 17p-diol (3a-diol) were studied in man. Clearance than expected from information on in vitro binding in plasma. The kinetic data is of interest since 3a-diol has a calculated inner pool (Vi) volume of 12-14 liters, similar to 1713-hydroxyandrost-4-en-3-one (testosterone) and 5a-androstan-1713-ol-3-one (dihydrotestosterone), but the calculated outer pool (V2) of 33.5 liters is very large as are the metabolic rate and transfer constants. In contrast to testosterone and dihydrotestosterone, 3a-diol, although bound to sex hormone binding globulin, has a high metabolic clearance of which a large fraction represents extrahepatic (splanchnic) metabolism. A production rate of 3a-diol similar to dihydrotestosterone together with rather unique kinetic characteristics encourages further investigation of the biological role of this potent androgen.
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been used to characterize this phenomenon (6) . Blood testosteronel in the female and prepubertal male is derived from secreted andros-4-ene-3,17-dione (androstenedione). Additionally, there is now evidence that testosterone, although the major circulating androgen, is converted peripherally by target tissue and perhaps other sites to 5a-androstan-17f-ol-3-one (dihydrotestosterone, DHT) which appears to be an important steroid messenger in sexual target tissue (7) (8) (9) (10) .
Are there other testosterone conversion products with important target tissue actions? One potential conversion product is 5a-androstane-3a,17p-diol (3a-androstanediol, 3a-diol) which has approximately equal potency as an androgen as testosterone (11) (12) (13) .
This report describes a kinetic in vivo study of this steroid. Blood concentrations, clearance rates, and production rates were determined and calculations were made suggesting its origin and clearance by splanchnic tissue. The study concludes that this steroid androgen has rather unique characteristics in terms of an unusually high extrasplanchnic metabolism.
METHODS
Solvents. All solvents were spectrograde and purchased from Matheson, Coleman, and Bell, Cincinnati, Ohio.
Radioactive steroids. [1,2- 'H] DHT (sp act: 44 Ci/mmol) and [4- "C]DHT (sp act: 56.1 mCi/mmol) were obtained from New England Nuclear (Boston, Mass.) and were further purified in the Bush B3 paper system (petroleum ether, benzene, methanol, water, 33: 17: 40,10) as previously described (14) . [1,2- 'H]3a-diol was made by reducing [1,2-'H] 3a-hydroxy-5a-androstan-17-one (androsterone) (sp act: 53 Ci/mmol, New England Nuclear) with 17/3-hydroxysteroid dehydrogenase, also as previously described, which was then purified with the Bush A (petroleum ether, methanol, water, 5: 4:1) and sequentially by the Bush B3 paper systems (15) . ["C]3a-diol was prepared by sodium borohydride reduction of [4-"C]DHT. Approxi-'Nomenclatnfre and abbreviations for the steroids used in this study: 3a-androstanediol (3a-diol), 5a-androstane-3a,-17,p-diol; 3p-androstanediol (3,8-diol) , 5a-androstane-3,,-17,8-diol; androstenedione, androst-4-ene-3,17-dione; androsterone, 3a-hydroxy-5a-androstan-17-one; dihydrotestosterone (DHT), 5a-androstan-17j3-ol-3-one; testosterone (T), 17,3- hydroxyandrost-4-en-3-one.
The Journal of Clinical Investigation Volume 54 September 1974 646-653 mately 3 AtCi of [4-14C] DHT was taken into a round bottom flask, and taken to dryness. After 0.1 ml of 0.1% NaBH4 (Matheson, Coleman, and Bell) methanol solution was added to the flask, the reaction was allowed to proceed for 10 min at room temperature. 1 ml of water was then added to stop the reaction, and the reaction mixture was extracted twice with 10 ml of dichloromethane. The extract was then washed twice with 5 ml of water and taken to dryness.
[14C]3a-diol was separated from [4-14C] -DHT by using the Bush B3 (for 3 h) and the Bush A (for 18 h) systems. The yield of ['4C]3a-diol was approximately 10%. DHT, Sa-androstane-3/3,173-diol (3p-diol), and testosterone are clearly separated from 3a-diol by these paper systems (16) .
The radiochemical purity of the [1,2-H]3a-diol and ['4C]3a-diol was confirmed as follows: Aliquots of both substances were mixed and counted (3H/14C ratio: 4.24) and then one-half of the remaining mixture was chromatographed on the Bush A system for 18 h (3H/'4C ratio: 4.13). The other half was acetylated and run in the Bush B3 system for 3 h (3H/'4C ratio: 4.28).
Constant infusion method. Normal volunteers, who had given informed consent, (five men and four women) were infused with [1,2-2H]3a-diol in order to measure metabolic clearance rates by the constant infusion technique as previously described (3, 16) . Patients were kept supine for 1 h and blood samples were drawn f or measurement of plasma 3a-diol concentrations. A single priming dose of , and 90 min. The plasma was separated and frozen until the measurement was done. After quantitation of each isotope and correction of losses as will be described later, the radioactivities expressed as the percent of injected dose per liter plasma were plotted on a semilogarithmic graph against time following injection.
A conversion ratio (CR) 2 in blood is ordinarily calculated as the ratio of counts per minute 3H per liter, corrected for recovery, of product to precursor during constant infusion of labeled precursor. When calculated from single injection data (at 60 min) it must be regarded as only an approximation to steady-state approaches.
Measuremtent of hepatic extraction. Hepatic extraction of 3a-diol was estimated by direct analysis of the peripheral and hepatic venous blood during a continuous infusion of [4-4C] DHT indicators, and extracted twice with three vol of dichloromethane after alkalinization with 0.4-0.6 ml of 4 N NaOH. The extract was washed twice with 5-10 ml of water, and then taken to dryness under vacuum.
In order to purify [1,2-3H]3a-diol, the Bush A system was used for 18 h, and for purification of [1,2-3H]DHT the Bush B3 system was then used for 2 h. The samples corresponding to ±1.5 cm from the center of the parallel standards were cut out and eluted into counting vials with 10 ml of methanol by using the syringe technique. The dried samples in scintillation fluid were then counted in a Mark I scintillation spectrometer (Nuclear-Chicago Corp., Des Plaines, Ill.). The characteristics for counting 3H and '4C were as described previously (3).
Evidence for radiochecmical puiritY of [1,2-3H]3a-diol isolated from plasma during infusion. 20 ml of pooled plasma was extracted during an infusion after addition of [F4C]3a-diol indicator, and chromatographed on the Bush A paper system for 18 h. After purification, two-thirds of the sample was acetylated and run again in the Bush A system for 1l h. The calculated 3H/'4C ratios before and after acetylation were 2.54 and 2.64, respectively.
Evidence that the steady state in plasma was attained during the constant infusion. Analysis of radioactivity as the purified [1,2-3H]3a-diol which was corrected for recovery from the two plasma specimens obtained at 105 and 120 min after the priming dose infusion did not indicate a trend in values. When the value at 120 min was taken as comparison, the mean value at 105 min was 98±+1.2 (SE)%. This shows no significant trend in values and that equilibrium was attained. Additionally, a 4-h infusion was performed in both a male and female subject. The data over this longer period with multiple sampling from 105 to 240 min show no trend in values (Table I) the single injection data predicts that a constant level should be reached by 80 min. Estimation of plasma 3a-diol. Plasma 3a-diol concentration was measured by using a specific and sensitive radioimmunoassay developed in our laboratory. This technique involves extraction of 3a-diol with labeled indicator, purification by paper chromatography (Bush A), location by direct scanning of the indicator, and immunoassay using a relatively specific antibody (15) .
Calculation of metabolic clearance and blood production rates of 3a-diol by constant infusion method. Metabolic clearance rates (MCR) were determined as previously described (3) . Blood production rate (PR) was calculated individually as the product of MCR and a.m. plasma 3a-diol concentration.
Analysis of plasma disappearance curves of radioactive steroids. When (2) This type of disappearance curve can be analyzed on the basis of a working two-compartment model if metabolism occurs only in the inner pool as previously proposed by Tait et al. (17, 18) . Other models may be as representative but we have chosen the one favored by most of those studying steroid kinetics in vivo (Fig. 1) .
The inner pool volume (V5), which is in rapid equilibrium with plasma, is determined by 1/(A + B). The apparent volume of the outer pool (V2) can be estimated by assuming that the steroid concentrations are the same in both pools in the steady-state situation with the following equations: (4) in an alternate model where steroid production occurs in the outer compartment (V2).
RESULTS
Metabolic clearance rate. The metabolic clearance rates of 3a-diol by the constant infusion method were 1,776+492 (SD) liters/day in five normal males and 1,297+219 liters/day in four normal females (Table  II) . The Table IV and Fig. 2 . Those data are also graphically illustrated for purposes of interpretation along with previously reported data obtained by us for testosterone (19) in Fig. 3 . The data reveal a unique aspect of the metabolism of 3a-diol. The volume of the inner pool (slower exchangeable pool) V1 of 3a-diol is similar to those of testosterone (11.8) and DHT (8.5 liters (Fig. 3) .
Hepatic (splanchnic) and extrahepatic clearance of 3a-diol. The hepatic extraction of 3a-diol determined directly by hepatic vein catheterization was 76.0% in three subjects during continuous infusion of 3a-diol (Table III) . 
DISCUSSION
The metabolic clearance rate obtained by the constant infusion technique for 3a-diol was 1,776±492 liters/day in men and 1,297±219 in women. The metabolic clearance of 3a-diol obtained by single injection was in good agreement with the constant infusion data. The only available information on this in the literature is the report by Bird, Choong, Knight, and Clark (21) .
Blood production rates of 3a-diol were calculated as the product of metabolic clearance and plasma concentration in the supine position. The calculated production rates are clearly arbitrary since any possible circadian variation or short-term fluctuations are ignored in our calculation. A single study of 3a-diol levels throughout the day in a male subject did not reveal any major long-term changes (unpublished data). Our calculations appear justified for comparative purposes since testosterone and DHT production rates have thus far been calculated based upon short-term sampling. With these limitations in mind, the calculated blood production rates of 3a-dioi in men are similar to production rates of DHT, although female production rates are only about one-half that of DHT (16) .
Previous studies have indicated that blood DHT in men is derived primarily from the peripheral conversion of testosterone (16) . Mahoudeau, Bardin, and Lipsett have also published conversion data for testosterone to 3a-diol (22) . Their data only allowed calculation of the fraction of plasma 3a-diol arising in testosterone (conversion ratio) since clearance rates of 3a-diol were not available. The conversion ratio of testosterone (T) to 3a-diol (CR TB3a) was 0.013 and that of DHT to 3a-diol (CRBDHT3a) was 0.153. In agreement with their data our CRBDHT-3a calculated during single injection of [1,2-3H] DHT is also 15% at 1 h. The more important conversion rate constant is the transfer constant (p) value defined as the fraction of a precursor converted to a product per unit time. This can be cal- the overall metabolic clearance of either DHT or testosterone (Fig. 4) . Progesterone has somewhat similar characteristics since it is partially bound in plasma (transcortin) and has both a high hepatic and extrahepatic clearance.
With the assumptions inherent in a two-compartment model without metabolism in the outer pool (liver considered to be in the inner pool) and considering equal concentration throughout, 3a-diol has three interesting characteristics. As shown in Table IV and Fig.  3 the rate of metabolism in the inner pool (Ko1 = 160) and the interpool transfer (K21= 137) is very high while the calculated volume of the outer pool (V2= 35 liters) is also large. Both the information on hepatic and extrahepatic clearance and the compartmental analysis imply a distinct metabolism for 3a-diol quite different from testosterone or dihydrotestosterone. One interpretation, obviously speculative, is the possibility of high affinity binding of 3a-diol particularly in extrahepatic tissue. High affinity binding of 3a-diol is not observed in sexual tissue (29). The role of 3a-diol as an anabolic messenger is one possibility and 3a-diol binding in muscle or other tissue should be looked for. In any event this potent androgen and anabolic steroid is produced in amounts in man similar to DHT in the circulation and has unexpectedly unique in vivo kinetic characteristics.
